Age, Biography and Wiki

Georg Winterer was born on 9 July, 1961, is an entrepreneur. Discover Georg Winterer's Biography, Age, Height, Physical Stats, Dating/Affairs, Family and career updates. Learn How rich is He in this year and how He spends money? Also learn how He earned most of networth at the age of 62 years old?

Popular As N/A
Occupation N/A
Age 62 years old
Zodiac Sign Cancer
Born 9 July, 1961
Birthday 9 July
Birthplace N/A

We recommend you to check the complete list of Famous People born on 9 July. He is a member of famous entrepreneur with the age 62 years old group.

Georg Winterer Height, Weight & Measurements

At 62 years old, Georg Winterer height not available right now. We will update Georg Winterer's Height, weight, Body Measurements, Eye Color, Hair Color, Shoe & Dress size soon as possible.

Physical Status
Height Not Available
Weight Not Available
Body Measurements Not Available
Eye Color Not Available
Hair Color Not Available

Dating & Relationship status

He is currently single. He is not dating anyone. We don't have much information about He's past relationship and any previous engaged. According to our Database, He has no children.

Parents Not Available
Wife Not Available
Sibling Not Available
Children Not Available

Georg Winterer Net Worth

His net worth has been growing significantly in 2022-2023. So, how much is Georg Winterer worth at the age of 62 years old? Georg Winterer’s income source is mostly from being a successful entrepreneur. He is from . We have estimated Georg Winterer's net worth , money, salary, income, and assets.

Net Worth in 2023 $1 Million - $5 Million
Salary in 2023 Under Review
Net Worth in 2022 Pending
Salary in 2022 Under Review
House Not Available
Cars Not Available
Source of Income entrepreneur

Georg Winterer Social Network




From 2009 to 2012 he was a research group leader at the Cologne Center for Genomics (CCG) at the University of Cologne, and from 2006 to 2012 an Associate Scientist at the Research Center Jülich of the Helmholtz Association (Institute for Neurosciences). Since 2012, Georg Winterer has been a research group leader at the Experimental & Clinical Research Center of the Charité - Universitätsmedizin Berlin.


In 2006, Vice-Rector Jürgen Schrader appointed Georg Winterer a lifetime W2 professor for psychiatry at the Clinic for Psychiatry and Psychotherapy of the Heinrich Heine University in Düsseldorf. There, Winterer was a senior physician in charge of the clinic and head of the consultative psychiatry department.


From 1995 to 1997 Winterer worked as a scientific assistant in the laboratory for psychophysiology at the Free University of Berlin as well as accompanying specialist outpatient and consultant medical work. In 2001 Georg Winterer completed his habilitation with a thesis on the "Physiology of Prefrontal Function". As a Clinical Research Fellow and Fogarty Fellow of the Global Health Fellowship Program, he conducted research from 1997 to 2003 at the National Institutes of Health (NIMH / NIAAA) in Bethesda, USA.


In the course of his earlier scientific work, Winterer discovered that in addiction disorders (alcohol and tobacco) a disturbed function of the frontal lobe (overactivation of the frontal lobe) predicts an unfavorable course of the disease (especially relapse). In more than ten years of research (1994–2007), Winterer discovered that a disorder of the frontal brain function (reduced signal-to-noise ratio with increased noise during information processing) is associated with a (genetically) increased risk of schizophrenia. The corresponding studies are the basis of one of the most frequently cited simulation models (Computational Neural Network Model) of the impaired brain function in schizophrenia. Winterer is also the first to describe a risk signature (clinical, imaging, molecular) that increases the risk in older surgical patients after an operation to suffer cognitive impairments, which in turn is associated with a significantly increased mortality and considerable socio-economic costs.


Winterer studied human medicine, philosophy and German studies at the Free University of Berlin. He received his doctorate in 1991 with an experimental epidemiological work at the Institute for Medical Psychology. In 1997 he completed his Residency in neurology / intensive care medicine, neurophysiology and psychiatry and in the emergency service at the Brandenburg State Hospital and the Free University of Berlin.


Since the early 1990s, Winterer worked as a study physician and consultant (CNS phase 1 / phase 2 studies) at the clinical research organization Parexel, initially in Berlin and later in Washington DC. After returning to Germany, he founded Pharmaimage Biomarker Solutions GmbH. In the first few years, the company's business model consisted primarily of supporting the research-based pharmaceutical industry in Germany and the European Union in carrying out drug studies (approval studies phase 1/2: first-in-man and first-in-patient studies). In 2016, the subsidiary Pharmaimage Biomarker Solutions Inc. was founded in Cambridge (Kendall Square) near Boston (USA). In 2019, Winterer founded PI Health Solutions GmbH and PI Insure Solutions GmbH under the umbrella of the PI Solutions Group GmbH holding. PI Health Solutions GmbH is a developer of AI-supported diagnostic software for the risk prediction of the course of diseases (e.g. BioCog software). At the same time, the company provides logistical service for the implementation of studies in the health sector (excluding pharmaceuticals), e.g.  in the context of a study financed by the German Federal Ministry of Health since June 2020 "SARS-CoV-2: A dynamic nationwide representative study (Corona-BUND study)".


Georg Winterer (born July 9, 1961) is a German entrepreneur, neuroscientist and specialist in psychiatry and psychotherapy. He is an Associate Professor at the Charité – University Medicine Berlin, director of the Neuroimaging Research Group in the Experimental and Clinical Research Center (ECRC) at the Charité – University Medicine Berlin. He is the founder and managing director of the Berlin PI Solutions Group GmbH.